Shares of Brenntag AG (OTCMKTS:BNTGY - Get Free Report) have received an average rating of "Reduce" from the nine ratings firms that are presently covering the firm, Marketbeat reports. Three equities research analysts have rated the stock with a sell recommendation and six have given a hold recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $12.80.
A number of equities research analysts have recently commented on BNTGY shares. Morgan Stanley cut shares of Brenntag from an "equal weight" rating to an "underweight" rating in a report on Tuesday, January 6th. Barclays upgraded shares of Brenntag to a "hold" rating in a report on Thursday, January 15th.
View Our Latest Stock Report on BNTGY
Brenntag Stock Performance
BNTGY opened at $13.62 on Friday. The business's 50-day simple moving average is $12.44 and its 200 day simple moving average is $11.83. Brenntag has a 52-week low of $10.19 and a 52-week high of $14.14. The firm has a market capitalization of $9.83 billion, a PE ratio of 33.22 and a beta of 0.66.
Brenntag (OTCMKTS:BNTGY - Get Free Report) last posted its quarterly earnings results on Thursday, March 12th. The company reported ($0.04) EPS for the quarter, missing analysts' consensus estimates of $0.24 by ($0.28). Brenntag had a net margin of 1.71% and a return on equity of 5.88%. The firm had revenue of $4.09 billion for the quarter, compared to analysts' expectations of $4.22 billion. On average, research analysts forecast that Brenntag will post 0.9 earnings per share for the current year.
About Brenntag
(
Get Free Report)
Brenntag SE, trading on OTCMKTS as BNTGY, is a global market leader in the distribution of chemicals and ingredients. With headquarters in Essen, Germany, the company serves a wide range of industries including coatings and construction, cleaning and water treatment, food and nutrition, pharmaceuticals and personal care, as well as oil and gas. Brenntag operates through two core segments—Essentials and Specialties—offering both standard commodity chemicals and tailored specialty solutions to customers around the world.
Its product portfolio encompasses inorganic and organic chemicals, polymers, petrochemicals and specialty ingredients.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Brenntag, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Brenntag wasn't on the list.
While Brenntag currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.